Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,450 total articles

Cycurion, Inc. Enters into Asset Purchase Agreement to Acquire Kustom Entertainment’s Legacy Video Solutions Segment, Delivering Non-Dilutive Scale, Access to Approximately 1,000 New Clients and a Robust Portfolio of Approximately 58 Patents

Cycurion, Inc. Enters into Asset Purchase Agreement to Acquire Kustom Entertainment’s Legacy Video Solutions Segment, Delivering Non-Dilutive Scale, Access to Approximately 1,000 New Clients and a Robust Portfolio of Approximately 58 Patents

Cycurion, Inc. announced an asset purchase agreement to acquire Kustom Entertainment's video solutions division, including Digital Ally-branded video systems used by law enforcement. The acquisition is expected to close in early July 2026, adding approximately 1,000 new clients, a portfolio of 58 patents, $5.1 million in annual revenue, and $8 mill…

Alliance Authentic Expands Its Preservation Platform Across Collecting, From Vinyl to Funko to Handmade by Robots

Alliance Authentic Expands Its Preservation Platform Across Collecting, From Vinyl to Funko to Handmade by Robots

Alliance Entertainment (Nasdaq: AENT) has broadened its Alliance Authentic preservation platform beyond vinyl records to include preserved Funko and Handmade by Robots collectibles. Each collectible is curated, numbered, limited, certified uncirculated, and NFC-secured to verify authenticity and ownership history, establishing a new category of per…

Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress

Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress

Biodexa Pharmaceuticals PLC announced that Health Canada has approved the expansion of its Phase 3 Serenta trial for treating familial adenomatous polyposis (FAP) into Canada. This trial, already active in the US and Europe, aims to enroll 168 patients to evaluate eRapa, an mTOR inhibitor addressing an unmet therapeutic need for FAP. Enrollment acc…

Quantum Cyber Signs Definitive Agreements to Acquire U.S.-Based Manufacturing Facility in Bridgeport, Connecticut

Quantum Cyber Signs Definitive Agreements to Acquire U.S.-Based Manufacturing Facility in Bridgeport, Connecticut

Quantum Cyber announced definitive agreements to acquire a 50,000-square-foot manufacturing facility and equipment in Bridgeport, Connecticut, marking a strategic shift to become a vertically integrated autonomous defense manufacturer. This move aligns with U.S. national security priorities emphasizing domestic drone production and positions the co…

WeShop Added to Russell 3000® and Russell Microcap® Indexes

WeShop Added to Russell 3000® and Russell Microcap® Indexes

WeShop Holdings Limited (NASDAQ: WSHP), a community-owned social commerce platform, has been added to the Russell 3000 and Russell Microcap Indexes following FTSE Russell's annual reconstitution. This inclusion reflects the company's growth, enhances its visibility with institutional investors, and underscores its commitment to long-term shareholde…

Mingteng International Reaches New Milestone in Global Expansion with Overseas Orders Serving Markets in Serbia, Vietnam and Mexico

Mingteng International Reaches New Milestone in Global Expansion with Overseas Orders Serving Markets in Serbia, Vietnam and Mexico

Mingteng International Corporation Inc., a Nasdaq-listed automotive mold supplier based in China, announced purchase agreements with three overseas enterprises in Serbia, Vietnam, and Mexico. This marks a significant milestone in the company's global expansion strategy, particularly in the new energy vehicle (NEV) sector. These contracts strengthen…

Star Equity Holdings Added to the Russell Microcap® Index

Star Equity Holdings Added to the Russell Microcap® Index

Star Equity Holdings, Inc. announced its common stock has been added to the Russell Microcap® Index following the 2026 reconstitution, reflecting its growth in market capitalization and enhancing its exposure to institutional and microcap investors. The company is a diversified holding firm operating across building solutions, business services, en…

Stran Expands Strategic Casino Market Presence with Industry Veteran Kevin Lewis to Accelerate Growth and Client Impact

Stran Expands Strategic Casino Market Presence with Industry Veteran Kevin Lewis to Accelerate Growth and Client Impact

Stran & Company, Inc., a leading provider of outsourced marketing solutions, expanded its presence in the casino sector by adding Kevin Lewis as a contracted sales representative. Lewis brings significant experience and a $5M+ existing business portfolio in casino gifting and branded merchandise, particularly within the Las Vegas gaming market. His…

Achieve Life Sciences Joins Russell 2000® Index

Achieve Life Sciences Joins Russell 2000® Index

Achieve Life Sciences, a late-stage pharmaceutical company developing cytisinicline for nicotine dependence, has been included in the Russell 2000 and Russell 3000 indexes following the 2026 reconstitution. This inclusion reflects its market capitalization and may attract institutional investor attention. Cytisinicline, supported by Phase 3 clinica…

Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment

Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment

Nexentis Technologies Inc. announced an addendum to loan agreements related to its Melz solar PV project in Germany, resulting in early partial loan repayments and a project valuation of $14.5 million, significantly above its initial investment. The transaction provides Nexentis liquidity while maintaining upside potential through retained profit r…

VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting

VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting

VivoSim Labs announced compelling data showcasing its AI-enabled 3D human tissue models' superior predictive accuracy for liver toxicity compared to traditional animal testing methods. Presentations at the European Society of Toxicology conference highlighted that VivoSim's NAMkind™ Liver models achieve over 90% sensitivity and fewer false positive…

Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026

Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026

Voyager Therapeutics announced a Developing Topics poster presentation at AAIC 2026 highlighting VY1706, their investigational gene therapy targeting tau protein for Alzheimer's disease. The FDA recently cleared the IND application for VY1706, allowing the start of clinical trials in early Alzheimer's patients, with dosing expected in the latter ha…